Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
For full access to this article login to GEN Select now.
Gauging Nanobiotech's Promise Realistically
Biotech and Pharma Firms Are Taking a Wait-and-See Approach
- Biotech products based on nanotechnology are becoming more widespread, but not without first encountering substantial challenges. According to a report issued by the ETC Group (www.etcgroup.org/en), the major pharmaceutical companies generally have been taking a wait-and-see attitude on nanotechnology. According to the report, and confirmed by a number ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.